Gallic Acid
CAS 149-91-7
Gallic Acid (CAS 149-91-7) is a Phase 2 pharmaceutical compound with 14 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 26450.52640625 nM | 61 | - |
| - | Potency | 18849.32295081967 nM | 54 | - |
| - | MIC | 571.075 ug.mL-1 | 20 | - |
| - | IC50 | 12.176315789473684 ug.mL-1 | 19 | - |
| - | Ki | 6521.538461538462 nM | 13 | - |
| - | EC50 | 14989.2125 nM | 8 | - |
| - | MIC | 31.25375 ug | 8 | - |
| - | EC50 | 3.4 ug.mL-1 | 5 | - |
| - | AC50 | 30127.233333333334 nM | 3 | - |
| - | MIC | 196033.33333333334 nM | 3 | - |
| - | EC50 | 2.5 ug | 2 | - |
| - | Kd | 1454 1/Ms | 1 | - |
| - | Kd | 1.34 10'-3/s | 1 | - |
| - | Kd | 924 nM | 1 | - |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| carbonic anhydrase 1 CA1 |
Inhibition | 5.5 pKi | 20185318 |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Gallic Acid used for in pharmaceutical contexts?
Gallic Acid (CAS 149-91-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Gallic Acid?
No adverse-event association or SIDER side-effect rows are rendered for Gallic Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Gallic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Gallic Acid with EU status "permitted".
What clinical phase is Gallic Acid in?
Gallic Acid is rendered with ChEMBL max phase 2.